Terkko Navigator / Grönhagen-Riska, C.

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease

Cumulative Risk of End-Stage Renal Disease Among Patients With Type 2 Diabetes: A Nationwide Inception Cohort Study

Type 2 diabetic patients on renal replacement therapy: Probability to receive renal transplantation and survival after transplantation

Impact of CKD on Household Income

Factors associating with differences in the incidence of renal replacement therapy among elderly: data from the ERA-EDTA Registry

One- and 2-Year Mortality Prediction for Patients Starting Chronic Dialysis

Incidence of End-Stage Renal Disease in Patients With Type 1 Diabetes

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation

Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis

Kidney Versus Combined Kidney and Liver Transplantation in Young People With Autosomal Recessive Polycystic Kidney Disease: Data From the European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant (ESPN/ERA-

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)

Gender Disparities in Access to Pediatric Renal Transplantation in Europe: Data From the ESPN/ERA-EDTA Registry

Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)

Racial Disparities in Access to and Outcomes of Kidney Transplantation in Children, Adolescents, and Young Adults: Results From the ESPN/ERA-EDTA (European Society of Pediatric Nephrology/European Renal Association-European Dialysis and Transplant As

Anemia in children following renal transplantation-results from the ESPN/ERA-EDTA Registry

Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA Registry

What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?

Biochemical variables and survival of patients with type 1 diabetes on renal replacement therapy

Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registry

Effects of lowering LDL cholesterol on progression of kidney disease

Pretransplant dialysis duration and risk of death after kidney transplantation in the current era

The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection

Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP)

Medication among patients with type 1 diabetes and predialytic renal disease

Adult height in patients with advanced CKD requiring renal replacement therapy during childhood

Modality of chronic renal replacement therapy and survival--a complete cohort from Finland, 2000-2009

Impact of graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric population

New primary renal diagnosis codes for the ERA-EDTA

Effect of vascular comorbidities on survival of type 2 diabetes patients on renal replacement therapy

Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy

Employment of patients receiving maintenance dialysis and after kidney transplant: a cross-sectional study from Finland

Decline in the incidence of renal failure due to amyloidosis associated with inflammatory rheumatic diseases

Decline in glomerular filtration rate during pre-dialysis phase and survival on chronic renal replacement therapy

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Comorbidities and survival of patients with type 1 diabetes on renal replacement therapy

A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland

Survival of patients with type 1 diabetes receiving renal replacement therapy in 1980-2007

Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland

Demographics of paediatric renal replacement therapy in Europe: 2007 annual report of the ESPN/ERA-EDTA registry

Improved survival of type 2 diabetic patients on renal replacement therapy in Finland

An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006

Inflammation in renal transplantation

The Nephrocare project: referral, patient case-mix, follow-up and quality of renal care in Nordic renal centres

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

Is Cystatin C more sensitive than creatinine in detecting early chronic allograft nephropathy?

No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases -- data from the Finnish national registry for kidney diseases

Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy

IL5RA and TNFRSF6B gene variants are associated with sporadic IgA nephropathy

International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality

Tyypin 1 diabetes ja krooninen munuaistauti